Nuria Izaguirre-Pérez, Gertrudis Ligero, Paula Alba Aguilar-Solana, José Antonio Carrillo-Ávila, Carmen Ruth Rodriguez-Reyes, Ida Biunno, Rocío Aguilar-Quesada, Purificación Catalina
{"title":"人脐带间充质干细胞的海藻糖低温保存。","authors":"Nuria Izaguirre-Pérez, Gertrudis Ligero, Paula Alba Aguilar-Solana, José Antonio Carrillo-Ávila, Carmen Ruth Rodriguez-Reyes, Ida Biunno, Rocío Aguilar-Quesada, Purificación Catalina","doi":"10.1089/bio.2024.0025","DOIUrl":null,"url":null,"abstract":"<p><p>Adequate hypothermic storage of human mesenchymal stem cells (hMSCs) is of fundamental importance since they have been explored in several regenerative medicine initiatives. However, the actual clinical application of hMSCs necessitates hypothermic storage for long periods, a process that requires the use of non-toxic and efficient cryo-reagents capable of maintaining high viability and differentiating properties after thawing. Current cryopreservation methods are based on cryoprotectant agents (CPAs) containing dimethylsulphoxide (DMSO), which have been shown to be toxic for clinical applications. In this study, we describe a simple and effective trehalose (TRE)-based solution to cryo-store human umbilical cord-derived MSCs (UC-MSCs) in liquid nitrogen. Cells viability, identity, chromosomal stability, proliferative and migration capacity, and stress response were assessed after cryopreservation in TRE as CPA, testing different concentrations by itself or in combination with ethylene glycol (EG). Here we show that TRE-stored UC-MSCs provided lower cell recovery rates compared with DMSO-based solution, but maintained good functional properties, stability, and differentiating potential. The best cell recovery was obtained using 0.5 M TRE with 10% EG showing no differences in the osteogenic, adipogenic, and chondrogenic differentiation capacity. A second cycle of cryopreservation in this TRE-based solution had no additional impact on the viability and morphology, although slightly affected cell migration. Furthermore, the expression of the stress-related genes, <i>HSPA1A</i>, <i>SOD2</i>, <i>TP53</i>, <i>BCL-2</i>, and <i>BAX</i>, did not show a higher response in UC-MSCs cryopreserved in 0.5 M TRE + 10% EG compared with DMSO. Together these results, in addition to ascertained therapeutic properties of TRE, provide sufficient evidence to consider TRE-based medium as a low-cost and efficient solution for the storage of human UC-MSCs cells and potentially substitute DMSO-based cryo-reagents.</p>","PeriodicalId":55358,"journal":{"name":"Biopreservation and Biobanking","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trehalose Cryopreservation of Human Mesenchymal Stem Cells from Cord Tissue.\",\"authors\":\"Nuria Izaguirre-Pérez, Gertrudis Ligero, Paula Alba Aguilar-Solana, José Antonio Carrillo-Ávila, Carmen Ruth Rodriguez-Reyes, Ida Biunno, Rocío Aguilar-Quesada, Purificación Catalina\",\"doi\":\"10.1089/bio.2024.0025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Adequate hypothermic storage of human mesenchymal stem cells (hMSCs) is of fundamental importance since they have been explored in several regenerative medicine initiatives. However, the actual clinical application of hMSCs necessitates hypothermic storage for long periods, a process that requires the use of non-toxic and efficient cryo-reagents capable of maintaining high viability and differentiating properties after thawing. Current cryopreservation methods are based on cryoprotectant agents (CPAs) containing dimethylsulphoxide (DMSO), which have been shown to be toxic for clinical applications. In this study, we describe a simple and effective trehalose (TRE)-based solution to cryo-store human umbilical cord-derived MSCs (UC-MSCs) in liquid nitrogen. Cells viability, identity, chromosomal stability, proliferative and migration capacity, and stress response were assessed after cryopreservation in TRE as CPA, testing different concentrations by itself or in combination with ethylene glycol (EG). Here we show that TRE-stored UC-MSCs provided lower cell recovery rates compared with DMSO-based solution, but maintained good functional properties, stability, and differentiating potential. The best cell recovery was obtained using 0.5 M TRE with 10% EG showing no differences in the osteogenic, adipogenic, and chondrogenic differentiation capacity. A second cycle of cryopreservation in this TRE-based solution had no additional impact on the viability and morphology, although slightly affected cell migration. Furthermore, the expression of the stress-related genes, <i>HSPA1A</i>, <i>SOD2</i>, <i>TP53</i>, <i>BCL-2</i>, and <i>BAX</i>, did not show a higher response in UC-MSCs cryopreserved in 0.5 M TRE + 10% EG compared with DMSO. Together these results, in addition to ascertained therapeutic properties of TRE, provide sufficient evidence to consider TRE-based medium as a low-cost and efficient solution for the storage of human UC-MSCs cells and potentially substitute DMSO-based cryo-reagents.</p>\",\"PeriodicalId\":55358,\"journal\":{\"name\":\"Biopreservation and Biobanking\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biopreservation and Biobanking\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/bio.2024.0025\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopreservation and Biobanking","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/bio.2024.0025","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
人间充质干细胞(hMSCs)的充分低温储存是至关重要的,因为它们已经在几个再生医学计划中进行了探索。然而,hMSCs的实际临床应用需要长期低温储存,这一过程需要使用无毒高效的冷冻试剂,能够在解冻后保持高活力和分化特性。目前的冷冻保存方法是基于含有二甲基亚砜(DMSO)的冷冻保护剂(cpa),这在临床应用中已被证明是有毒的。在这项研究中,我们描述了一种简单有效的基于海藻糖(TRE)的解决方案,用于在液氮中冷冻储存人脐带来源的间充质干细胞(UC-MSCs)。通过单独或与乙二醇(EG)联合使用不同浓度的TRE冷冻保存后,评估细胞活力、身份、染色体稳定性、增殖和迁移能力以及应激反应。本研究表明,与基于dmso的溶液相比,tre3储存的UC-MSCs提供了较低的细胞回收率,但保持了良好的功能特性、稳定性和分化潜力。使用0.5 M TRE和10% EG获得最佳细胞回收率,在成骨、成脂和成软骨分化能力方面没有差异。在这种基于trec的溶液中进行第二轮冷冻保存对细胞的活力和形态没有额外的影响,尽管对细胞迁移有轻微的影响。此外,与DMSO相比,在0.5 M TRE + 10% EG中冷冻保存的UC-MSCs中,应激相关基因HSPA1A、SOD2、TP53、BCL-2和BAX的表达并没有表现出更高的反应。综上所述,除了确定了TRE的治疗特性外,这些结果提供了足够的证据,证明基于TRE的培养基是一种低成本、高效的储存人UC-MSCs细胞的解决方案,并有可能取代基于dmso的冷冻试剂。
Trehalose Cryopreservation of Human Mesenchymal Stem Cells from Cord Tissue.
Adequate hypothermic storage of human mesenchymal stem cells (hMSCs) is of fundamental importance since they have been explored in several regenerative medicine initiatives. However, the actual clinical application of hMSCs necessitates hypothermic storage for long periods, a process that requires the use of non-toxic and efficient cryo-reagents capable of maintaining high viability and differentiating properties after thawing. Current cryopreservation methods are based on cryoprotectant agents (CPAs) containing dimethylsulphoxide (DMSO), which have been shown to be toxic for clinical applications. In this study, we describe a simple and effective trehalose (TRE)-based solution to cryo-store human umbilical cord-derived MSCs (UC-MSCs) in liquid nitrogen. Cells viability, identity, chromosomal stability, proliferative and migration capacity, and stress response were assessed after cryopreservation in TRE as CPA, testing different concentrations by itself or in combination with ethylene glycol (EG). Here we show that TRE-stored UC-MSCs provided lower cell recovery rates compared with DMSO-based solution, but maintained good functional properties, stability, and differentiating potential. The best cell recovery was obtained using 0.5 M TRE with 10% EG showing no differences in the osteogenic, adipogenic, and chondrogenic differentiation capacity. A second cycle of cryopreservation in this TRE-based solution had no additional impact on the viability and morphology, although slightly affected cell migration. Furthermore, the expression of the stress-related genes, HSPA1A, SOD2, TP53, BCL-2, and BAX, did not show a higher response in UC-MSCs cryopreserved in 0.5 M TRE + 10% EG compared with DMSO. Together these results, in addition to ascertained therapeutic properties of TRE, provide sufficient evidence to consider TRE-based medium as a low-cost and efficient solution for the storage of human UC-MSCs cells and potentially substitute DMSO-based cryo-reagents.
Biopreservation and BiobankingBiochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
自引率
12.50%
发文量
114
期刊介绍:
Biopreservation and Biobanking is the first journal to provide a unifying forum for the peer-reviewed communication of recent advances in the emerging and evolving field of biospecimen procurement, processing, preservation and banking, distribution, and use. The Journal publishes a range of original articles focusing on current challenges and problems in biopreservation, and advances in methods to address these issues related to the processing of macromolecules, cells, and tissues for research.
In a new section dedicated to Emerging Markets and Technologies, the Journal highlights the emergence of new markets and technologies that are either adopting or disrupting the biobank framework as they imprint on society. The solutions presented here are anticipated to help drive innovation within the biobank community.
Biopreservation and Biobanking also explores the ethical, legal, and societal considerations surrounding biobanking and biorepository operation. Ideas and practical solutions relevant to improved quality, efficiency, and sustainability of repositories, and relating to their management, operation and oversight are discussed as well.